Back to results
US 11,185,581 B2Granted
Human rotavirus G9P[6] strain and use as a vaccine
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsBaoming Jiang, Yuhuan Wang
Life of this patent
Estimating the term…
Abstract
Attenuated G9P[6] rotavirus is disclosed herein. In some embodiments, pharmaceutical compositions are disclosed that include an attenuated G9P[6] rotavirus, or a component thereof. These compositions can be used to induce an immune response, such as a protective immune response, to a rotavirus. The compositions can be used as vaccines, such as for children (infants), for example in a prime boost strategy.
Claims19
An isolated polypeptide, comprising an amino acid sequence at least 99.3% identical to the amino acid sequence of SEQ ID NO:
- 4.
Dependencies are inferred from the claim text.